Ardent Health Partners, Inc. (ARDT)
(Real Time Quote from BATS)
$17.78 USD
+0.16 (0.91%)
Updated Oct 9, 2024 03:16 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Ardent Health Partners, Inc. (ARDT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$22.30 | $27.00 | $19.00 | 26.56% |
Price Target
Based on short-term price targets offered by 10 analysts, the average price target for Ardent Health Partners, Inc. comes to $22.30. The forecasts range from a low of $19.00 to a high of $27.00. The average price target represents an increase of 26.56% from the last closing price of $17.62.
Analyst Price Targets (10)
Broker Rating
Ardent Health Partners, Inc. currently has an average brokerage recommendation (ABR) of 1.35 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms. The current ABR compares to an ABR of 1.35 a month ago based on 10 recommendations.
Of the 10 recommendations deriving the current ABR, seven are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 70% and 20% of all recommendations. A month ago, Strong Buy made up 70%, while Buy represented 20%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | NA |
Buy | 2 | 2 | 2 | 2 | NA |
Hold | 1 | 1 | 1 | 1 | NA |
Sell | 0 | 0 | 0 | 0 | NA |
Strong Sell | 0 | 0 | 0 | 0 | NA |
ABR | 1.35 | 1.35 | 1.35 | 1.35 | NA |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/12/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Not Available | Strong Buy |
8/12/2024 | SVB Securities | Whit Mayo | Not Available | Strong Buy |
8/12/2024 | Truist Securities | David S Macdonald | Not Available | Strong Buy |
8/12/2024 | Stephens | Scott Fidel | Not Available | Strong Buy |
8/12/2024 | Loop Capital Markets | Timothy Greaves | Not Available | Strong Buy |
8/12/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
8/12/2024 | Not Identified | Not Identified | Not Available | Moderate Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.35 |
ABR (Last week) | 1.35 |
# of Recs in ABR | 10 |
Average Target Price | $22.30 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 182 of 252 |
Current Quarter EPS Est: | 0.31 |
ARDT FAQs
Ardent Health Partners, Inc. (ARDT) currently has an average brokerage recommendation (ABR) of 1.35 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms.
The average price target for Ardent Health Partners, Inc. (ARDT) is $22.30. The current on short-term price targets is based on 6 reports.
The forecasts for Ardent Health Partners, Inc. (ARDT) range from a low of $19 to a high of $27. The average price target represents a increase of $26.56 from the last closing price of $17.62.
The current UPSIDE for Ardent Health Partners, Inc. (ARDT) is 26.56%
Based on short-term price targets offered by 10 analysts, the average price target for Ardent Health Partners, Inc. comes to $22.30. The forecasts range from a low of $19.00 to a high of $27.00. The average price target represents an increase of 26.56% from the last closing price of $17.62.